RE:RE:And there you have it. They've been misleading retail investors for along time sad to say. A point last year with PMN 310 when Joann Kaplan annouced at the Alzheimers conference in July/22 that the company would be filing the IND in the 4th quarter/2022. We know how that went delay, delay, why didn't they do a financing back in May if they were serious about going into the clinic at a much higher share price. It can't be more obvious what they have done over the last 4 months, starting Apr 28th when the stock was gaining momentum. Taking the stock down to an all time low since 2007,2008 from a high of $8.95 a month ago to today's price does everyone now agree that the Boston fix is in. I'm sure the same Boston group players are getting 95% of this placement. This won't last them long as the have at the end of June 8 million in unpaid bills on the balance sheet A/P. The boldness of what they have just done!